HC Deb 10 January 2000 vol 342 cc54-5W
Mrs. Brinton

To ask the Secretary of State for Health what recent steps his Department has taken to analyse the potential impact of new technologies in improving the accuracy of diagnosis of cervical smears. [100255]

Yvette Cooper

We are aware of a number of new technologies under development, which are closely monitored by the National Health Service cervical screening programme. For example, the National Institute for Clinical Excellence have been asked to consider the evidence and advise on whether liquid-based cytology would offer worthwhile benefits.

We welcome any new technology that would improve the effectiveness and efficiency of the cervical screening programme. However, before any technology is introduced we must be sure that it is safe and effective, and that quality standards can be maintained.

Mr. Mitchell

To ask the Secretary of State for Health what plans he has for making the Neopath Autopap for cervical screening available in(a) the NHS and (b) Grimsby NHS Trust. [100338]

Yvette Cooper

The Tripath Autopap system (previously Neopath Autopap system) is currently being evaluated by the National Health Service cervical screening programme.

We welcome any new technology that would improve the effectiveness and efficiency of the cervical screening programme. However, before any technology is introduced we must be sure that it is safe and effective, and that quality standards can be maintained.

Forward to